Plan B Approval is Not Assured


The Chicago Tribune puts the FDA’s seeming about-turn on Plan B in (cautionary) context:

FDA approval for over-the-counter sales is not assured. One potential hurdle: the FDA wants the company to ensure that pharmacies won’t sell the pill over the counter to girls younger than age 18. But isn’t that the pharmacies’ responsibility? Some advocates worry that such an onerous requirement could be a loophole that would allow the FDA to deny permission for over-the-counter sales.

Dr. Susan Wood, former director of the FDA’s Office of Women’s Health, resigned in protest last August after the last Plan B delay. She said she was “somewhat encouraged” by Monday’s announcement. But she also warned: “I feel they’re making it appear they’re moving forward. But until we actually see a decision, we can’t count on that.” Yes, some skepticism is warranted here. Unfortunately, politics may yet trump science again.

FACT:

Mother Jones was founded as a nonprofit in 1976 because we knew corporations and the wealthy wouldn't fund the type of hard-hitting journalism we set out to do.

Today, reader support makes up about two-thirds of our budget, allows us to dig deep on stories that matter, and lets us keep our reporting free for everyone. If you value what you get from Mother Jones, please join us with a tax-deductible donation today so we can keep on doing the type of journalism 2019 demands.

We Recommend

Latest

Sign up for our newsletters

Subscribe and we'll send Mother Jones straight to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate

We have a new comment system! We are now using Coral, from Vox Media, for comments on all new articles. We'd love your feedback.